Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Description

CBER seeks to support several research projects that are focused on developing novel technologies for the advanced manufacturing of complex biologic products or innovative analytical approaches for improving product manufacturing and quality.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

Gordana Zuber <br/>Grant Management Specialist <br/>Phone: 301-348/1747
gordana.zuber@fda.hhs.gov

Key dates & funding
  • PostedMar 14, 2021
  • ClosesMay 18, 2021
  • Award floor$0
  • Award ceiling$500,000
  • Program funding$2,000,000
  • Expected awards4
  • CFDA93.103

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro